Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Garreta, E; Moya-Rull, D; Stanifer, ML; Monteil, V; Prado, P; Marco, A; Tarantino, C; Gallo, M; Jonsson, G; Hagelkruys, A; Mirazimi, A; Boulant, S; Penninger, JM; Montserrat, N.
Protocol for SARS-CoV-2 infection of kidney organoids derived from human pluripotent stem cells.
STAR Protoc. 2022; 3(4): 101872
Doi: 10.1016/j.xpro.2022.101872
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Jonsson Gustav
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- This protocol presents the use of SARS-CoV-2 isolates to infect human kidney organoids, enabling exploration of the impact of SARS-CoV-2 infection in a human multicellular in vitro system. We detail steps to generate kidney organoids from human pluripotent stem cells (hPSCs) and emulate a diabetic milieu via organoids exposure to diabetogenic-like cell culture conditions. We further describe preparation and titration steps of SARS-CoV-2 virus stocks, their subsequent use to infect the kidney organoids, and assessment of the infection via immunofluorescence. For complete details on the use and execution of this protocol, please refer to Garreta et al. (2022).1.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- COVID-19 - administration & dosage
- SARS-CoV-2 - administration & dosage
- Cell Differentiation - administration & dosage
- Kidney - administration & dosage
- Pluripotent Stem Cells - administration & dosage
- Organoids - administration & dosage